Clinical Trial Update: Pilot Study of the Efficacy of Nicotinamide (Vitamin B3) in Leber's Hereditary Optic Neuropathy [Phase 1]

View source ↗

Summary

Phase 1 pilot trial evaluating nicotinamide (vitamin B3) for efficacy in Leber hereditary optic neuropathy; study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leber Hereditary Optic Neuropathy
• Mitochondrial Disease
• Optic Neuropathy

Drugs mentioned

• Nicotinamide (nicotinamide)

Snippet

Sponsor: University Hospital, Angers | Conditions: Leber Hereditary Optic Neuropathy (LHON), Leber's Hereditary Optic Neuropathy (LHON) | Phase 1 | Status: NOT_YET_RECRUITING